undamentalytics Newsletter

Richmond Timothy J.: insider trades

Officer at AbbVie. No open-market purchases and 18 sales not made under a pre-set plan, reported from February 7, 2014 to March 2, 2023.

What happened after Richmond Timothy J.’s sales?

After their sales, the shares moved +3.5% against the index over 12 months on average (a negative figure means selling was the right call); 56% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Richmond Timothy J.: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 18 +1.6% +1.4% 39% 10 0.35 0.73 No reliable evidence
Sales, 12 months after the report 18 +3.5% −0.8% 56% 10 0.49 0.64 No reliable evidence
Sales, 12 months after the trade 18 +2.6% −2.7% 56% 10 0.34 0.74 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
AbbVie ABBV EVP, CHIEF HR OFFICER018February 7, 2014March 2, 2023

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
March 2, 2023March 1, 2023 ABBV Sale $6,766,147 −17.8%−7.9%−12.0%
December 14, 2022December 12, 2022 ABBV Sale $6,925,018 −5.3%−25.7%−22.7%
March 1, 2022March 1, 2022 ABBV Sale $3,918,807 +4.6%+14.5%+14.5%
December 8, 2021December 6, 2021 ABBV Sale $6,042,000 +30.9%+50.9%+53.0%
March 2, 2021March 1, 2021 ABBV Sale $2,119,025 −4.9%+30.4%+29.1%
December 1, 2020November 27, 2020 ABBV Sale $5,458,950 −2.2%−9.8%−12.8%
May 7, 2020May 5, 2020 ABBV Sale $1,652,825 −2.9%+0.2%−5.1%
October 1, 2019September 27, 2019 ABBV Sale $1,163,935 +12.6%+8.4%+7.9%
June 19, 2018June 15, 2018 ABBV Sale $1,749,478 −11.9%−24.7%−24.8%
March 2, 2018February 28, 2018 ABBV Sale $2,151,368 −14.8%−33.3%−33.0%
December 19, 2017December 18, 2017 ABBV Sale $8,569,088 +3.7%−1.3%−6.5%
March 10, 2017March 10, 2017 ABBV Sale $1,465,826 +3.9%+69.3%+66.1%
May 12, 2016May 10, 2016 ABBV Sale $1,370,952 +2.1%−8.1%−9.9%
March 2, 2016February 29, 2016 ABBV Sale $708,294 +11.4%−4.3%−7.2%
March 3, 2015February 27, 2015 ABBV Sale $868,032 +10.9%−0.9%−0.3%
February 19, 2015February 17, 2015 ABBV Sale $14,147 +6.5%−0.7%+3.4%
February 19, 2014February 18, 2014 ABBV Sale $23,824 +0.5%+5.0%+2.5%
February 7, 2014February 5, 2014 ABBV Sale $69,766 +0.7%+1.3%+5.4%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Richmond Timothy J. traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.